Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration

  • Authors:
    • Gina D. McShan
    • Radoslaw Zagozdzon
    • Shin-Young Park
    • Sheila Zrihan-Licht
    • Yigong Fu
    • Shalom Avraham
    • Hava Avraham
  • View Affiliations

  • Published online on: July 1, 2002     https://doi.org/10.3892/ijo.21.1.197
  • Pages: 197-205
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Our recent observations indicated that RAFTK (also termed Pyk2 and CAK-β) participated in intracellular signaling upon heregulin (HRG) stimulation and promoted breast carcinoma invasion. Furthermore, studies from our group indicate that the Csk homologous kinase (CHK), a member of the Csk family, directly associates with HER2/Neu and down-regulates HER2/Neu-mediated Src kinase activation in breast cancer cells upon heregulin stimulation. Since activation of RAFTK is associated with the activity of Src family kinases, we analyzed whether CHK is capable of opposing HRG-induced activation of RAFTK. Stimulation of human T47D breast cancer cells with HRG induced the tyrosine phosphorylation of RAFTK and its association with CHK in vitro and in vivo. This interaction was mediated through the Src binding site (amino acid residue at 402) of RAFTK and the SH2 domain of CHK. RAFTK phosphorylation downstream of the activated HER2/Neu was greatly reduced in the presence of CHK. Maximal inhibition of RAFTK phosphorylation by CHK required the kinase activity of CHK. Furthermore, CHK inhibited the tyrosine phosphorylation of the focal adhesion-associated protein, paxillin, and inhibited HRG-induced T47D breast cancer cell migration. These findings indicate the role of CHK as a negative regulator in HRG- and RAFTK-mediated intracellular signaling in breast cancer cells.

Related Articles

Journal Cover

July 2002
Volume 21 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
McShan GD, Zagozdzon R, Park S, Zrihan-Licht S, Fu Y, Avraham S and Avraham H: Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration. Int J Oncol 21: 197-205, 2002
APA
McShan, G.D., Zagozdzon, R., Park, S., Zrihan-Licht, S., Fu, Y., Avraham, S., & Avraham, H. (2002). Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration. International Journal of Oncology, 21, 197-205. https://doi.org/10.3892/ijo.21.1.197
MLA
McShan, G. D., Zagozdzon, R., Park, S., Zrihan-Licht, S., Fu, Y., Avraham, S., Avraham, H."Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration". International Journal of Oncology 21.1 (2002): 197-205.
Chicago
McShan, G. D., Zagozdzon, R., Park, S., Zrihan-Licht, S., Fu, Y., Avraham, S., Avraham, H."Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration". International Journal of Oncology 21, no. 1 (2002): 197-205. https://doi.org/10.3892/ijo.21.1.197